Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Central Nervous System Drugs Market Research Reports
Central Nervous System Drugs Market Research Reports
| Title | published | price | |
|---|---|---|---|
Opium Withdrawal Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Opium Withdrawal Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 02-May-2022 | $2000 | |
Pervasive Developmental Disorder (PDD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Pervasive Developmental Disorder (PDD) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pervasive Developmental Disorder (PDD), complete with analysis by Stage of Development, D......" | 02-May-2022 | $2500 | |
Panic Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Panic Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2000 | |
Primary Progressive Multiple Sclerosis (PPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... verview of the Primary Progressive Multiple Sclerosis (PPMS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Primary Progressive Multiple Sclerosis (PPMS), complete with analysi......" | 02-May-2022 | $2000 | |
Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... vides comprehensive information on the therapeutics under development for Psychosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the d......" | 02-May-2022 | $2000 | |
Dementia Associated With Alzheimers Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... view of the Dementia Associated With Alzheimer's Disease pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Dementia Associated With Alzheimer's Disease, complete with analysis by ......" | 02-May-2022 | $2000 | |
Diabetic Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 02-May-2022 | $2000 | |
Dystonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... es comprehensive information on the therapeutics under development for Dystonia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descr......" | 02-May-2022 | $2000 | |
Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ng Multiple Sclerosis (RMS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Relapsing Multiple Sclerosis (RMS), complete with analysis by Stage of Development, Drug Target, Mech......" | 02-May-2022 | $2000 | |
Relapsing Remitting Multiple Sclerosis (RRMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... verview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with analysi......" | 02-May-2022 | $2000 | |
| | |||